CP
Insider
Cole Pinnow
Chief Commercial OfficerCole Pinnow (Chief Commercial Officer) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Cogent Biosciences, Inc. (COGT). Across 1 priced purchase filing, the average 21-session return was +7.0% from execution and +2.3% from disclosure (delay-adjusted; derived). The largest single filing was $332K of COGT (43,750 sh × $7.60, as filed), executed Jan 14 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+7.0%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+2.3%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$332K
shares × price, as filed
Last traded
Jan 14 2025
Filed Jan 15 2025
Median ADV $84.0M across their filed names
Open performance→Volume by month
Buys $332K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
COGTRecent filings
COGTPURCHASE
Cogent Biosciences, Inc.
View filing →
$332K43,750 sh × $7.60
Exec Jan 14 2025
Filed Jan 15 2025 · 5:30 PM ET